These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28188032)

  • 1. Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept.
    Epelbaum S; Genthon R; Cavedo E; Habert MO; Lamari F; Gagliardi G; Lista S; Teichmann M; Bakardjian H; Hampel H; Dubois B
    Alzheimers Dement; 2017 Apr; 13(4):454-467. PubMed ID: 28188032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.
    Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P
    Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for preclinical Alzheimer's disease.
    Tan CC; Yu JT; Tan L
    J Alzheimers Dis; 2014; 42(4):1051-69. PubMed ID: 25024325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.
    Edmonds EC; Bangen KJ; Delano-Wood L; Nation DA; Furst AJ; Salmon DP; Bondi MW;
    J Int Neuropsychol Soc; 2016 Nov; 22(10):978-990. PubMed ID: 27903335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility.
    Mortamais M; Ash JA; Harrison J; Kaye J; Kramer J; Randolph C; Pose C; Albala B; Ropacki M; Ritchie CW; Ritchie K
    Alzheimers Dement; 2017 Apr; 13(4):468-492. PubMed ID: 27702618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Ritchie K; Ropacki M; Albala B; Harrison J; Kaye J; Kramer J; Randolph C; Ritchie CW
    Alzheimers Dement; 2017 Feb; 13(2):186-195. PubMed ID: 27702619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Alzheimer's Disease: Implications for Refinement of the Concept.
    Vos SJB; Visser PJ
    J Alzheimers Dis; 2018; 64(s1):S213-S227. PubMed ID: 29865060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emergence of a New Conceptual Framework for Alzheimer's Disease.
    Dubois B
    J Alzheimers Dis; 2018; 62(3):1059-1066. PubMed ID: 29036825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
    Hampel H; Lista S; Khachaturian ZS
    Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new definition for Alzheimer's disease].
    Dubois B
    Bull Acad Natl Med; 2013 Jan; 197(1):143-53; discussion 153-6. PubMed ID: 24672986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
    van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
    Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.
    Jessen F; Amariglio RE; van Boxtel M; Breteler M; Ceccaldi M; Chételat G; Dubois B; Dufouil C; Ellis KA; van der Flier WM; Glodzik L; van Harten AC; de Leon MJ; McHugh P; Mielke MM; Molinuevo JL; Mosconi L; Osorio RS; Perrotin A; Petersen RC; Rabin LA; Rami L; Reisberg B; Rentz DM; Sachdev PS; de la Sayette V; Saykin AJ; Scheltens P; Shulman MB; Slavin MJ; Sperling RA; Stewart R; Uspenskaya O; Vellas B; Visser PJ; Wagner M;
    Alzheimers Dement; 2014 Nov; 10(6):844-52. PubMed ID: 24798886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmonized diagnostic criteria for Alzheimer's disease: recommendations.
    Morris JC; Blennow K; Froelich L; Nordberg A; Soininen H; Waldemar G; Wahlund LO; Dubois B
    J Intern Med; 2014 Mar; 275(3):204-13. PubMed ID: 24605805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease.
    Buckley RF; Villemagne VL; Masters CL; Ellis KA; Rowe CC; Johnson K; Sperling R; Amariglio R
    J Mol Neurosci; 2016 Nov; 60(3):354-361. PubMed ID: 27514526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
    Lista S; Molinuevo JL; Cavedo E; Rami L; Amouyel P; Teipel SJ; Garaci F; Toschi N; Habert MO; Blennow K; Zetterberg H; O'Bryant SE; Johnson L; Galluzzi S; Bokde AL; Broich K; Herholz K; Bakardjian H; Dubois B; Jessen F; Carrillo MC; Aisen PS; Hampel H
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S171-91. PubMed ID: 26402088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in cerebrospinal fluid biomarkers for the detection of preclinical Alzheimer's disease.
    Kulic L; Unschuld PG
    Curr Opin Neurol; 2016 Dec; 29(6):749-755. PubMed ID: 27805971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.
    Szalárdy L; Zádori D; Klivényi P; Vécsei L
    J Alzheimers Dis; 2016 May; 53(2):373-92. PubMed ID: 27163812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.